Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
American Society of Clinical Oncology confers highest honor upon Prof Hagop Kantarjian 2023-06-05 12:30
Live from ASCO 2023 | Updated Data of Olverembatinib in SDH-Deficient GIST including a CBR of 93.8% Signals a Potential Clinical Breakthrough 2023-06-05 11:51
LOTTE BIOLOGICS to Kick off their CDMO Business Campaign at 'BIO International Convention 2023' 2023-06-05 08:27
VVN539 met primary study endpoints in US phase IIa clinical study for the treatment of glaucoma 2023-06-05 08:00
Gracell Biotechnologies Presents Updated Data of Deep and Durable Responses for FasTCAR-T GC012F in Relapsed/Refractory Multiple Myeloma at 2023 ASCO Annual Meeting 2023-06-04 02:15
TWi Biotechnology Exploring Promising Treatment for Granuloma Annulare (GA) 2023-06-02 15:51
GC Biopharma receives a business license for the construction of a plasma fractionation plant and technology transfer in Indonesia 2023-06-02 08:35
GenEros to Present Promising Results of GEC255 Phase I Clinical Trial for Advanced NSCLC Patients with KRAS G12C Mutation 2023-06-01 22:15
Impact Therapeutics Entered into Global Partnership with Eikon Therapeutics to Develop and Commercialize PARP1 Selective Inhibitors 2023-06-01 20:30
Aravax doses first patient in Phase 2 peanut allergy clinical trials 2023-06-01 20:00
Kombucha Continues to Trend! TCI Received the Golden Award at the Geneva International Exhibition of Inventions 2023-06-01 18:06
WuXi Biologics to Increase Manufacturing Capacity in Germany 2023-06-01 16:49
Amplo Biotechnology Secures Fast Track STTR Funding for AMP-201, a Promising Gene Therapy Targeting Collagen Q Deficiency 2023-06-01 04:24
Actinogen to present progress on Cognitive Impairment in Depression and Alzheimer's Disease Phase 2 trials at the BIO International Convention 2023-05-31 20:58
QBIOTICS TO PRESENT AT SACHS 9TH ANNUAL IMMUNO-ONCOLOGY INNOVATION FORUM AND THE BIO INTERNATIONAL CONVENTION 2023-05-31 19:00
Asieris' progress in MIBC receives renewed attention with its inclusion in ASCO 2023 2023-05-31 16:00
Yuhan Corporation and J INTS BIO inked a licensing agreement for a New Drug Candidate targeting HER2 NSCLC 2023-05-31 13:02
Ascentage Pharma's Novel Drug Olverembatinib Recommended for a Breakthrough Therapy Designation in China for the Treatment of SDH-Deficient GIST, the Second BTD for the Drug 2023-05-31 10:20
Inmagene to Participate in the Jefferies Healthcare Conference on June 8 2023-05-30 20:00
Lunit and the Japan National Cancer Center Hospital East Partner in AI Pathology to Advance Precision Oncology 2023-05-30 20:00
1 50 51 52 53 54 222